Download PDF
Facial Plast Surg 2019; 35(03): 274-277
DOI: 10.1055/s-0039-1688943
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Overview of Kybella (Deoxycholic Acid Injection) as a Fat Resorption Product for Submental Fat

Michael Liu
1   Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California
,
Cameron Chesnut
2   University of Washington School of Medicine, Spokane, Washington
3   Chesnut MD Cosmetic Surgery Fellowship at Dermatology Specialists of Spokane, Spokane, Washington
,
Gary Lask
1   Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
12 June 2019 (online)

    Permissions and Reprints

Abstract

There has been an increasing interest in addressing the issue of submental fat (SMF) when it comes to cosmetic medicine. With the rise of social media, video calls, and the now almost omnipresent accessibility of cameras, there is perhaps now more than ever an emphasis on the facial image. Although invasive procedures such as liposuction and neck lift still play a significant role in reducing SMF, the trend toward minimally invasive methods has finally given rise to a single Food and Drug Administration-approved injectable that is both safe and effective: ATX-101, also known as Kybella in the United States.

Keywords

Kybella - submental fat - deoxycholic acid
 

  • References

  • 1 ASDS Consumer Survey on Cosmetic Dermatologic Procedures. 2018 ; Available at: https://www.asds.net/Medical-Professionals/Practice-Resources/ASDS-Consumer-Survey-on-Cosmetic-Dermatologic-Procedures . Accessed
    PubMed
  • 2 Baumann L, Shridharani SM, Humphrey S, Gallagher CJ. Personal (Self) perceptions of submental fat among adults in the United States. Dermatol Surg 2019; 45 (01) 124-130
    CrossrefPubMedGoogle Scholar
  • 3 Chin Surgery Skyrockets Among Women and Men in All Age Groups. 2012. Available at: https://www.plasticsurgery.org/news/press-releases/chin-surgery-skyrockets-among-women-and-men-in-all-age-groups 2019 . Accessed
    PubMed
  • 4 Raveendran SS, Anthony DJ, Ion L. An anatomic basis for volumetric evaluation of the neck. Aesthet Surg J 2012; 32 (06) 685-691
    CrossrefPubMedGoogle Scholar
  • 5 Mahmud K, Crutchfield CE. Lipodissolve for body sculpting: safety, effectiveness, and patient satisfaction. J Clin Aesthet Dermatol 2012; 5 (10) 16-19
    PubMedGoogle Scholar
  • 6 Libby B, Ruha A, Raschke R, Wong M. Multisystem organ failure following LipoDissolve injections. J Clin Toxicol 2013; 3: 2161–0495.1000171
    PubMedGoogle Scholar
  • 7 2010 Warning Letters - Health Fraud 2015; Available at: https://www.fda.gov/ForConsumers/ProtectYourself/HealthFraud/ucm431944.htm 2019 . Accessed
    PubMed
  • 8 Wollina U, Goldman A. ATX-101 for reduction of submental fat. Expert Opin Pharmacother 2015; 16 (05) 755-762
    CrossrefPubMedGoogle Scholar
  • 9 Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004; 30 (07) 1001-1008
    PubMedGoogle Scholar
  • 10 Ascher B, Fellmann J, Monheit G. ATX-101 (deoxycholic acid injection) for reduction of submental fat. Expert Rev Clin Pharmacol 2016; 9 (09) 1131-1143
    CrossrefPubMedGoogle Scholar
  • 11 Dayan SH, Humphrey S, Jones DH. , et al. Overview of ATX-101 (deoxycholic acid injection): a nonsurgical approach for reduction of submental fat. Dermatol Surg 2016; 42 (Suppl. 01) S263-S270
    CrossrefPubMedGoogle Scholar
  • 12 Yagima Odo ME, Cucé LC, Odo LM, Natrielli A. Action of sodium deoxycholate on subcutaneous human tissue: local and systemic effects. Dermatol Surg 2007; 33 (02) 178-188 , discussion 188–189
    PubMedGoogle Scholar
  • 13 Walker P, Fellmann J, Lizzul PF. A phase I safety and pharmacokinetic study of ATX-101: injectable, synthetic deoxycholic acid for submental contouring. J Drugs Dermatol 2015; 14 (03) 279-287
    PubMedGoogle Scholar
  • 14 Walker P, Lee D. A phase 1 pharmacokinetic study of ATX-101: serum lipids and adipokines following synthetic deoxycholic acid injections. J Cosmet Dermatol 2015; 14 (01) 33-39
    CrossrefPubMedGoogle Scholar
  • 15 Dover J, Schlessinger J, Young L, Walker P. Reduction of submental fat with ATX-101: results from a phase IIB study using investigator, subject, and magnetic resonance imaging assessments. Paper presented at: Journal of the American Academy of Dermatology 2012
    PubMedGoogle Scholar
  • 16 Goodman G, Lee D, Smith K, Walker P. Reduction of submental fat with ATX-101: a pooled analysis of two international multicenter, double-blind, randomized, placebo-controlled studies. J Am Acad Dermatol 2012; 66 (04) AB11
    PubMedGoogle Scholar
  • 17 Humphrey S, Sykes J, Kantor J. , et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol 2016; 75 (04) 788-797.e7
    CrossrefPubMedGoogle Scholar
  • 18 Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol 2014; 28 (12) 1707-1715
    CrossrefPubMedGoogle Scholar
  • 19 Jones DH, Carruthers J, Joseph JH. , et al. REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction. Dermatol Surg 2016; 42 (01) 38-49
    CrossrefPubMedGoogle Scholar
  • 20 Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study. Br J Dermatol 2014; 170 (02) 445-453
    CrossrefPubMedGoogle Scholar
  • 21 Full Prescribing Information. Kybella. Available at: https://www.allergan.com/assets/pdf/kybella_pi . Accessed January 20, 2019
  • 22 Jones DH, Kenkel JM, Fagien S. , et al. Proper technique for administration of ATX-101 (deoxycholic acid injection): insights from an injection practicum and roundtable discussion. Dermatol Surg 2016; 42 (Suppl. 01) S275-S281
    CrossrefPubMedGoogle Scholar
  • 23 Sorenson E, Chesnut C. Marginal mandibular versus pseudo-marginal mandibular nerve injury with submandibular deoxycholic acid injection. Dermatol Surg 2018; 44 (05) 733-735
    CrossrefPubMedGoogle Scholar
  • 24 Sykes JM, Allak A, Klink B. Future applications of deoxycholic acid in body contouring. J Drugs Dermatol 2017; 16 (01) 43-46
    PubMedGoogle Scholar
  • 25 Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 2005; 53 (06) 973-978
    CrossrefPubMedGoogle Scholar